Integrating Buprenorphine Into the SFGH AIDS Program

Completed · Phase 4

Conditions studied: HIV, Buprenorphine, Opioid Dependence

In brief

The purpose of this study is to assess the feasibility, cost, and effectiveness of a model of care designed to integrate buprenorphine treatment for opioid dependence into the HIV primary care clinics at the UCSF Positive Health Program.

Key facts

Study ID: NCT00263458
Run by: University of California, San Francisco
People needed: 37
Starts: 2005-12-01
Expected to finish: 2009-06-01
Last updated by the study team: 2011-09-12

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Age > 18 years
Fluent in English
Receive HIV primary care at the UCSF Positive Health Program
Meet DSM-IVR criteria for opioid dependence
Meet clinical criteria for buprenorphine treatment (see Exclusion Criteria)
Plan to stay in the San Francisco Bay Area for the next 12 months

You may not qualify if…

Severe hepatic dysfunction, i.e., AST and/or ALT > 5X upper limit of normal
DSM-IV criteria for benzodiazepine abuse or dependence within the past 6 months
DSM-IV criteria for alcohol dependence within the past 6 months
Actively suicidal
Psychiatric impairment that impedes ability to consent (dementia, delusional, actively psychotic)
Methadone or opiate analgesic doses exceed level allowing for safe transition to buprenorphine
Pregnant women and women actively trying to become pregnant
Potential subjects also will be excluded for:
Any medical condition(s), which, in the opinion of the investigator, would interfere with the patient's ability to participate in or adhere to the requirements of this study
Unable or who decline to provide informed consent for the evaluation

Where it is running

UCSF Positive Health Program — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.